Full history for every metric is available with a Kvantra account
Stock profile
Cynosure, Inc. (CYNO)
Current price
66.00 USD0.00%
Last close 21 Mar 2017Benchmarks
Key financial summary
Financials in USD| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 111 | 153 | 226 | 292 | 339 | 434 | 434 |
| Operating profit | $m | 27 | 27 | |||||
| Net profit | $m | -3 | 11 | -2 | 31 | 16 | 14 | 14 |
| EPS reported | $ | 0.60 | 0.61 | |||||
| Operating cashflow per share | $ | - | 1.93 | |||||
| Capex per share | $ | - | 0.58 | |||||
| FCF per share | $ | - | 1.35 | |||||
| Free cash flow | $m | 32 | 32 | |||||
| Net debt | $m | -181 | -181 | |||||
| Book value equity | $m | 455 | 455 | |||||
| Book value per share | $ | 19.21 | 19.21 | |||||
| Number of shares | m | 23.71 | 23.71 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 2.33 | 3.38 | |||||
| P/S LTM | x | 2.45 | 0.00 | |||||
| P/FCF LTM | x | 33.66 | 0.00 | |||||
| EV/EBITDA LTM | x | 21.55 | -3.11 | |||||
| EV/Sales LTM | x | - | -0.31 | |||||
| Earnings Yield LTM | % | - | 0.92% | |||||
| FCF Yield | % | 2.97% | - | |||||
| Quality | ||||||||
| ROE | % | - | 3.30% | |||||
| ROIC | % | - | 3.23% | |||||
| Operating margin | % | - | 6.31% | |||||
| Gross margin | % | - | 58.89% | |||||
| FCF/Sales | % | - | 7.28% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | -14.29% | -14.29% | |||||
| Sales Growth YoY | % | +27.71% | +27.71% | |||||
| Net Income Growth YoY | % | -10.16% | -10.16% | |||||
| FCF Growth | % | +17.21% | +17.21% | |||||
| Operating Profit Growth | % | +3.87% | +3.87% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | - | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | - | 0.00% | |||||
| FCF/Debt | x | 1.61 | 1.61 | |||||
| Net Debt/EBITDA | x | - | -3.11 | |||||
| EBIT/Net interest | x | - | 0.00 | |||||
| Net debt/market cap | % | -16.99% | - | |||||
| Net debt/Equity | x | -0.40 | -0.40 | |||||
| Gross debt/equity | x | 0.04 | 0.04 | |||||
Company overview
No description available.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
CY
Cynosure, Inc. (CYNO)
CYNO · NASDAQ · Healthcare
66.00 USD0.00%
Benchmarks
Financialsin USD
20152016TTM
Total revenue $m339434434
Operating profit $m2727
Net profit $m161414
EPS reported $0.600.61
About
No description available.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free